Kadia TM, Js C, Konopleva M, Borthakur G, Pemmaraju N, Daver N, Montalban-Bravo G, Issa G, Naqvi K, Short N, Dinardo C, Bhalla K, Jabbour E, Takahashi K, Sasaki K, Kornblau S, Malla R, Pierce S, Estrov Z, Andreeff M , Garcia-Manero G, Ravandi F, and Kantarjian H
GLP-1 therapy may also be appropriate for those looking for a medically supervised alternative to short-term dieting
Cora does not offer brand-name Zepbound) Ro only: approximately $598/month effective ($149 membership + $449 medication)
5 Map to model figures for selected features of Conformer 1 (a) and Conformer 2 (b)
The GLP-1 data presented to date are based on: Large observational cohort studies Retrospective comparative effectiveness analyses Meta-analytic pooling of observational datasets They are not yet based on dedicated randomized clinical trials designed specifically to evaluate colorectal cancer incidence or adenoma prevention as primary endpoints
As a physician, Narang is concerned that the buzz around GLP-1s is shifting attention to medication rather than treating diabetes and obesity as chronic conditions that require long-term, holistic care and medical follow-up